Impact of Closed-Loop Insulin Delivery System in the Management of Type 1 Diabetes
Abstract According to the CDC (2012), 13,000 youths are diagnosed with type 1 Diabetes every year. Type 1 Diabetes is an autoimmune disease in which the pancreas fails to secrete insulin. If not well managed, this condition can be fatal. Children and adolescents are of a particular concern because they are still in a psychosocial developmental stage that does not promote favorable behaviors towards the proper management of the disease. This paper is a review of the literature on closed-loop insulin delivery systems to evaluate whether they are better for the management of type 1 Diabetes than open-loop continuous insulin delivery systems. The databases searched were CINAHL and MEDLINE EBSCO using the following keywords: Closed-loop insulin delivery system, closed-loop insulin, and type 1 Diabetes. Out of 20 research papers reviewed, 5 were used for this review paper. The 5 research papers were published between the years of 2006 and 2010. The overall result showed that the closed-loop delivery systems were feasible in maintaining tight glycemic control in children and adolescents. While these studies highlighted the benefits of the closed-loop system, they were not specific to the adaptation of adolescents to the technology and their adherence to diabetic treatments. This subject is particularly important to nursing practice because nurses are the primary educators in the healthcare environment. By staying abreast of the evidence based practice of new technologies, nurses are able to properly care for their parents and increase their quality of life.
Introduction According to the Centers for Disease Control and Prevention (CDC, 2012), 13,000 youths are diagnosed with type 1 Diabetes Mellitus (DM) every year. It is an autoimmune disease in which the pancreas loses its ability to manufacture and secrete insulin. It is sometimes referred to as juvenile diabetes due to the fact that it tends to occur in children and young adults. Unlike Type 2 DM,
Introduction According to the Centers for Disease Control and Prevention (CDC, 2012), 13,000 youths are diagnosed with type 1 Diabetes Mellitus (DM) every year. It is an autoimmune disease in which the pancreas loses its ability to manufacture and secrete insulin. It is sometimes referred to as juvenile diabetes due to the fact that it tends to occur in children and young adults. Unlike Type 2 DM,
References: Anhalt, H. & Bohannon, N. (2010). Insulin patch pumps: Their development and future in closed-loop systems. Diabetes Technology & Therapeutics, 12(1), 51-52. doi: 10.1089/dia.2010.0016 Aronson, R Baser, O., Bouchard, J., DeLuzio, T., Henk, H., & Aagren, M. (2010). Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Advances In Therapy, 27(2), 94-104. McLeod, S. A. (2008). Psychosocial stages. Simply Psychology. Retrieved from http://www.simplypsychology.org/Erik-Erikson.html National Diabetes Information Clearinghouse (2008) Steil, G., Rebrin, K., Darwin, C., Hariri, F., & Saad, M. (2006). Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes, 55(12), 3344-3350. Thabit, H., & Hovorka, R